Grace Bird
YOU?
Author Swipe
View article: Nasopharyngeal Airspace Temperature During Rhinothermy
Nasopharyngeal Airspace Temperature During Rhinothermy Open
Background: Respiratory viruses such as influenza and human rhinoviruses are temperature sensitive. Rhinothermy delivers heated, humidified air to the upper airways via the nares, and by possibly inhibiting viral replication, it is propose…
View article: Rhinothermy delivered by nasal high flow therapy in the treatment of the common cold: a randomised controlled trial
Rhinothermy delivered by nasal high flow therapy in the treatment of the common cold: a randomised controlled trial Open
Background The common cold is the most common infectious disease affecting humans and has a substantial economic impact on society. Human rhinoviruses, which cause almost two-thirds of colds, have demonstrated temperature-dependent replica…
View article: Automatic versus manual oxygen titration using a novel nasal high-flow device in medical inpatients with an acute illness: a randomised controlled trial
Automatic versus manual oxygen titration using a novel nasal high-flow device in medical inpatients with an acute illness: a randomised controlled trial Open
Background Guideline recommendations state oxygen should be administered to acutely unwell patients to achieve a target oxygen saturation (SpO 2 ) range. The current practice of manual oxygen titration frequently results in SpO 2 outside o…
View article: Closed-Loop Oxygen Control Using a Novel Nasal High-Flow Device: A Randomized Crossover Trial
Closed-Loop Oxygen Control Using a Novel Nasal High-Flow Device: A Randomized Crossover Trial Open
This study provides proof-of-concept evidence that the novel nasal high-flow device with closed-loop control can respond to changes in [Formula: see text] outside a target saturation range using a model of exercise-induced desaturation and…
View article: Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma
Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma Open
Background and objective The dose-response relationship of inhaled corticosteroid (ICS)/fast-onset long acting beta agonist (LABA) reliever therapy has not been formally addressed. The objective of this retrospective analysis is to ascerta…
View article: Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma
Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma Open
adverse effects.Doses of ICS may be minimized by various measures, including environmental control, use of adjunct therapies such as long-acting inhaled bronchodilators, and in the more severe patient, by the early introduction of biologic…
View article: Protocol for a randomised, single-blind, two-arm, parallel-group controlled trial of the efficacy of rhinothermy delivered by nasal high flow therapy in the treatment of the common cold
Protocol for a randomised, single-blind, two-arm, parallel-group controlled trial of the efficacy of rhinothermy delivered by nasal high flow therapy in the treatment of the common cold Open
Introduction The common cold is the most common infectious disease affecting humans. It is usually a self-limiting disease; however, the common cold can cause significant morbidity and has a substantial economic impact on society. Human rh…
View article: Asthma paradoxes: time for a new approach across the spectrum of asthma severity
Asthma paradoxes: time for a new approach across the spectrum of asthma severity Open
We support the proposal that anti-inflammatory reliever therapy replaces the current use of short-acting β2-agonist reliever therapy in adults across the range of asthma severityhttp://ow.ly/uUtP30nHqhj
View article: The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity
The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity Open
A paradigm shift in asthma management that addresses the paradoxes of SABA reliever therapy is required; consideration needs to be given to replacement of SABA reliever with ICS/fast-onset β-agonist reliever therapy across the range of ast…